StockData
Gossamer Bio, Inc. logo

Gossamer Bio, Inc. (GOSS) stock

GOSSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 1/30
$11.43+0.39 (+3.53%)

Close on Nov 18, 2026Market cap $5.59BP/E –Yield –

Gossamer Bio market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Gossamer Bio's market cap was $71.43M on Nov 11, 2026, against $772.56M a year earlier. Over the last 5 years it ranged from $38.63M to $1.07B, with a median of $205.69M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$71.43M-90.0%
2025Dec 31, 2025$717.05M+249.8%
2024Dec 31, 2024$204.99M-0.3%
2023Dec 29, 2023$205.69M+0.9%
2022Dec 30, 2022$203.79M-76.1%
2021Dec 31, 2021$851.64M+21.5%
2020Dec 31, 2020$700.84M-26.5%
2019Dec 31, 2019$953.19M–

More Gossamer Bio figures

See a number that looks wrong?